Summary & Overview
HCPCS Level II J2597: Injection, Desmopressin Acetate, per 1 mcg
HCPCS Level II code J2597 denotes the injection of desmopressin acetate, billed per 1 mcg. This medication is used for conditions requiring desmopressin administration and is coded at the per‑microgram level to support precise billing for variable dosages. Nationally, accurate use of J2597 matters for precise medication accounting, appropriate payer reimbursement, and consistent clinical documentation across ambulatory and infusion settings.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how J2597 is defined, typical sites of service where the code is used, and which payers commonly process claims for injectable desmopressin. The publication outlines billing benchmarks, common modifier usage patterns where available, and relevant policy updates that affect coverage and payment for parenteral desmopressin.
The piece also provides clinical context for when desmopressin injections are administered, operational considerations for accurate service lines, and guidance on documentation elements required by major payers. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code J2597 represents an injection of desmopressin acetate, billed per 1 mcg. This code is used to report administration of the synthetic vasopressin analogue desmopressin in individual microgram increments.
-
Service type: Medication injection
-
Typical site of service: Outpatient clinic or other ambulatory settings where parenteral medication administration occurs (e.g., infusion center, physician office)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with central diabetes insipidus or nocturnal enuresis requiring short-term or intermittent parenteral desmopressin acetate dosing when oral or intranasal routes are contraindicated or not tolerated. The patient arrives to an ambulatory infusion clinic or hospital inpatient unit for administration of J2597 (injection, desmopressin acetate, per 1 mcg). The clinical workflow includes verification of indication and prior authorization if needed, review of recent serum sodium and volume status, informed consent, preparation of the correct microgram dose by pharmacy or trained nurse, administration via subcutaneous or intravenous injection per facility protocol, and post-dose monitoring for hyponatremia and fluid balance for several hours. Documentation includes medication administration record with lot number, dose in micrograms, route, site, patient response, and any adverse events. Billing captures the number of micrograms administered using units of J2597 and appropriate modifiers to reflect billing circumstances such as bilateral procedures, services by multiple providers, or billing adjustments.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Professional component | Use when billing only the professional component of a service when split billing applies and a facility bills the technical component. |